Like Avalere Health LLC

announced 8/26/2015 via Company Press Release

Inovalon, Inc., will acquire Avalere Health LLC

synopsis: Inovalon, a leading technology company providing cloud-based analytics and data-driven intervention platforms to the healthcare industry, has entered into a definitive agreement to acquire Avalere Health, Inc., a leading provider of data-driven advisory services and business intelligence solutions to the pharmaceutical and life sciences industry.
buyer: Inovalon, Inc. (INOV:$449.36)
Inovalon is a leading technology company that combines advanced cloud-based data analytics and data-driven intervention platforms to achieve meaningful insight and impact in clinical and quality outcomes, utilization, and financial performance across the healthcare landscape. "
target: Avalere Health LLC
Avalere Health, Inc. is a leading provider of data-driven advisory services and business intelligence solutions to the pharmaceutical and life sciences industry.
price ($mm)
$140
rev ($mm)
$47
EBITDA ($mm)
EV / rev
3.0x
EV / EBITDA
closed 5/21/2019 via BusinessWire

Xcenda, acquired Dymaxium, Inc.

synopsis: Xcenda, a part of AmerisourceBergen, announced the acquisition of Dymaxium, a trusted market access partner specializing in the exchange of evidence and information between payers and life science companies through its FormularyDecisions.com® platform.
buyer parent: AmerisourceBergen Corporation
buyer: Xcenda
Xcenda, part of AmerisourceBergen, is a strategic consultancy with 20+ years of experience applying real-world expertise in health economics and outcomes research, reimbursement, stakeholder insights, and market access consulting and communications. "
target: Dymaxium, Inc.
Dymaxium is a trusted market access partner specializing in the exchange of evidence and information between payers and life science companies through its FormularyDecisions.com® platform.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 10/7/2016 via BNC Analysis

M3, Inc., will acquire Vidal Group

synopsis: Electra Partners’ portfolio company AXIO Group has received a binding offer from M3 Inc. to purchase Vidal Group, a European provider of reference drug information. Vidal Group provides hospitals, primary care physicians, pharmacists, and patients with on-line access to up-to-date drug databases and related treatment-based information.
buyer: M3, Inc. (TSE:2413:$1,127.03)
M3 Inc. represents the three Ms of Medicine, Media, and Metamorphosis. Their company was founded with the goal of changing the world of medicine through making full use of the power of the Internet. "
target parent: Electra Partners LLP
target: Vidal Group
Vidal Group is a leading European healthcare informatics and information systems company. Vidal Group provides hospitals, primary care physicians, pharmacists, and patients across Europe with on-line access to up-to-date drug databases and related treatment-based information.
price ($mm)
$133
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/30/2016 via BNC Analysis

Affinity Equity Partners, will acquire MedicalDirector

synopsis: Leading Asian private equity firm Affinity Equity Partners agreed to acquire Sydney-based MedicalDirector (formerly Health Communication Network) from Australia’s Primary Health Care Ltd. MedicalDirector is a leading provider of clinical and enterprise software solutions to general practitioners, medical specialists and allied health professionals.
buyer: Affinity Equity Partners
Affinity Equity Partners is an independently-owned buyout fund manager comprising primarily the former investment professionals of UBS Capital Asia Pacific. They are pioneers in buyout investments in the Asia-Pacific region, with an established and widely recognised franchise. "
target parent: Primary Health Care Limited
target: MedicalDirector
MedicalDirector has been supporting healthcare professionals and improving health outcomes for more than 20 years. They provide software for practice management, optimizing patient outcomes, and access to Australia's most comprehensive and up-to-date pharmaceutical database.
price ($mm)
$119
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/11/2012 via BNC Analysis

Piramal Healthcare Limited, acquired Decision Resources Group

synopsis: Piramal Healthcare Limited has completed its previously announced acquisition of Decision Resources Group, a US based company in the healthcare information segment. Decision Resources Group is a cohesive portfolio of companies that offers best in class, high-value information and insights on important sectors of the healthcare industry.
buyer parent: Piramal Group
buyer: Piramal Healthcare Limited
With assets across North America, Europe and Asia, Piramal Healthcare is one of the largest pharmaceutical custom manufacturing companies across the world. It has significant presence in the global critical care space with sales of anesthesia products to over 100 countries. "
target parent: Providence Equity Partners Inc.
target: Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. The top biopharmaceutical, medical technology and managed care companies rely on the Company’s predictive analytics to make fully informed decisions.
price ($mm)
$635
rev ($mm)
$160
EBITDA ($mm)
EV / rev
4.0x
EV / EBITDA
closed 7/22/2010 via Company Press Release

CT Corsearch, acquired Edital

synopsis: CT Corsearch, the premier provider of clearance and protection solutions for trademark and brand professionals, announced it’s acquired Edital, the Questel trademark branch. This acquisition will create best-in-class solutions for managing a brand lifecycle globally—from creation to watching to protecting, maintaining and renewing a brand.
buyer parent: Wolters Kluwer NV
buyer: CT Corsearch
CT Corsearch provides high-quality, intuitive tools and expertise that trademark professionals need to effectively manage the trademark screening, search review and watching processes. "
target parent: Questel
target: Edital
Edital was established in Brussels in 1982 and acquired by Questel, a world leader in Intellectual Property in 2005. Its sole purpose has been to create global solutions for the Intellectual Property professional.
price ($mm)
rev ($mm)
$8
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
closed 9/27/2007 via PR Newswire

Thomson Pharma, acquired Prous Science

synopsis: The Thomson Corporation, a leading provider of information solutions to business and professional customers worldwide, today announced that it has acquired Prous Science, a global leader in the provision of life sciences information solutions. Prous Science will become part of Thomson Scientific.
buyer parent: The Thomson Corporation
buyer: Thomson Pharma (:$964.58)
Thomson Scientific & Healthcare provides integrated information solutions to researchers and librarians, physicians and pharmacists, and other professionals worldwide. "
target: Prous Science
Prous Science is a trusted source of information on which science depends to discover safer and more effective medicines. The company's products have evolved through the years from print journals to sophisticated electronic products incorporating the latest advances in IT.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/15/2007 via Company Description

MergerMarket, acquired Infinata, Inc.

synopsis: In September 2007, Mergermarket acquired Infinata, an information solutions and marketing analytics provider to the global financial service, life science, and high technology industries.
buyer parent: Pearson plc
buyer: MergerMarket
MergerMarket, part of Pearson's Financial Times Group, is an unparalleled, independent M&A intelligence tool used by the world's foremost financial institutions to originate deals. It provides proprietary intelligence on potential deal flow, potential mandates and valuations. "
target: Infinata, Inc.
Infinata is an innovative provider of information solutions and marketing analytics to the global financial service, life science, and high-tech industries. Our information suites include: BioPharm Insight, High Net Worth Insight, and Corporate Tracker.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/10/2007 via

Providence Equity Partners Inc., acquired Decision Resources, Inc.

synopsis: Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, announced today that Providence Equity Partners, a leading private equity firm with more than $21 billion under management, will acquire majority control of the Company.
buyer: Providence Equity Partners Inc.
Providence Equity Partners Inc. is a private investment firm specializing in equity investments in communications and media companies around the world. The principals of Providence Equity manage funds with approximately $21 billion in equity commitments. "
target parent: Boston Ventures Management, Inc.
target: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/6/2004 via PR Newswire

Boston Ventures Management, Inc., Castanea Partners, acquired Decision Resources, Inc.

synopsis: Castanea Partners and Boston Ventures Limited Partnership VI today announced the recapitalization of Decision Resources, Inc., with a total transaction value of $58 million. The Waltham, Massachusetts-based company is best known for its therapeutically-focused analyses of global pharmaceutical and biotechnology markets.
buyer: Boston Ventures Management, Inc.
buyer: Castanea Partners
Boston Ventures Management, LLC is a private equity firm that has been an active investor and financial partner to management teams in the media, entertainment, publishing and information and communications sectors since 1983, earning the firm a franchise position in the private equity community. "
target: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit.
price ($mm)
$58
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 10/7/2019 via BNC Analysis

Inflexion Private Equity Partners LLP, will acquire Pharmaspectra

synopsis: Inflexion Private Equity, a UK mid-market private equity firm, will acquire Pharmaspectra, a global provider of medical affairs data to the pharmaceutical and biotech industry. Pharmaspectra offers the world's largest database for medical scientific literature and biomedical literature.
buyer: Inflexion Private Equity Partners LLP
Inflexion is a UK mid-market private equity firm. They invest in high growth, entrepreneurial businesses and work with them to accelerate growth. Inflexion’s flexible approach allows it to back both majority and minority investments, typically investing £10m to £150m of equity in each deal. "
target: Pharmaspectra
Pharmaspectra is a global provider of medical affairs data to the pharmaceutical and biotech industry. Pharmaspectra offers the world's largest database for medical scientific literature and biomedical literature. Their web-based solutions analyze data across the entire medical continuum.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/3/2013 via Company Press Release

JISC Collections, acquired SpringerProtocols

synopsis: Springer announced that JISC Collections has purchased the archive content of SpringerProtocols; the world’s largest database of life sciences protocols. SpringerProtocols contains more than 31,000 protocols, most of which come from the classic book series “Methods in Molecular Biology”.
buyer: JISC Collections
JISC Collections supports the procurement of digital content for education and research in the UK. They are uniquely placed to provide members with: expertise in negotiating and procurement, within the scholarly communications sector. "
target parent: EQT
target: SpringerProtocols
SpringerProtocols combines the world’s largest collection of life sciences and bio-medicine protocols with advanced search functionality. Used primarily in the life sciences, the protocols provide sets of instructions that allow scientists to recreate experiments in their own laboratories.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/7/2013 via Wall Street Journal

Wilmington Group plc, acquired NHiS Ltd

synopsis: Wilmington Group plc, the provider of Information, Compliance, and Education to professional markets announced the acquisition of the entire issued and to be issued share capital of NHiS Limited. NHiS is a leading provider of business intelligence, data analysis, workflow tools and other services to pharmaceutical companies in the UK.
buyer: Wilmington Group plc (LSE:WIL:$162.62)
Wilmington Group plc is a dynamic and expanding company providing information and training to professional business markets. Their businesses enable professionals and their organizations to perform better by providing quality, relevant and reliable information, education and knowledge. "
target: NHiS Ltd
NHiS is the leading provider of market intelligence and insight to the pharmaceutical sector. NHiS’s products assist organizations in their understanding, engagement and optimization of their markets.
price ($mm)
$8.82
rev ($mm)
$3
EBITDA ($mm)
EV / rev
5.2x
EV / EBITDA
closed 9/13/2011 via PR Newswire

ImpactRx, Inc., acquired TargetRx, Inc.

synopsis: ImpactRx, a Symphony Technology Group company and the pioneer in measuring the impact of promotion on physician prescribing behavior, announced that it has acquired 100% of TargetRx, Inc., a leading provider of insight into the drivers of physician behavior for pharmaceutical companies.
buyer parent: Symphony Technology Group
buyer: ImpactRx, Inc.
ImpactRx is the leading provider of consultative and analytically-based promotional effectiveness solutions to the healthcare industry. ImpactRx's ImpactData™ is the industry’s sole source of continuous-capture market promotion and physician treatment data. "
target: TargetRx, Inc.
TargetRx, Inc. is a leading provider of insight into the drivers of physician behavior for pharmaceutical companies. The company offers a suite of solutions from pipeline to patent expiry.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/3/2016 via PR Newswire

IMS Health Incorporated, acquired AlphaImpactRx, Inc

synopsis: Symphony Technology Group announced the closing of the sale of AlphaImpactRx, a leading provider of primary research and analytics-based insight for biopharmaceutical and consumer health companies to IMS Health, a global information and technology services company serving the healthcare industry.
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading global information and technology services company providing clients in the healthcare industry with end-to-end solutions to measure and improve their performance. They connect configurable SaaS applications to complex healthcare data in the IMS One™ cloud platform. "
target parent: Symphony Technology Group
target: AlphaImpactRx, Inc
AlphaImpactRx is the leading provider of primary research-based insights, analytics and solutions to pharmaceutical, consumer health and medical device companies. They provide market research to help its global healthcare clients make informed and business decisions to market their products.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/18/2011 via PR Newswire

Symphony Technology Group, acquired ImpactRx, Inc.

synopsis: ImpactRx, the pioneer in measuring the impact of promotion on physician prescribing behavior, announced that Symphony Technology Group (STG), has acquired a majority ownership interest in the Company. STG is a leading private equity firm with a strategic focus on data, analytics and technology-enabled services companies.
buyer: Symphony Technology Group
Symphony Technology Group (STG) is a strategic private equity firm with the mission of investing in and building great software and services companies. STG also provides transformation expertise to enable its companies to deliver maximum value to its clients. "
target: ImpactRx, Inc.
ImpactRX annually captures three-million treatment decisions, fueling its unique ImpactData™ industry database. ImpactRx leverages this unprecedented intelligence with custom research and analytics to provide insightful solutions to pharmaceutical marketing and sales decision makers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/16/2015 via BNC Analysis

Sudler & Hennessey, acquired System Analytic Ltd.

synopsis: Sudler & Hennessey, has acquired a majority stake in System Analytic for an undisclosed sum. Sudler is a global healthcare marketing and communications network, while London-based System Analytic’s database and online tools enable pharmaceutical companies to identify, map and engage key opinions leaders across a broad range of medical fields.
buyer parent: WPP Group, plc
buyer: Sudler & Hennessey
Sudler & Hennessey is one of the world's leading healthcare communications firms, developing strategic promotional and educational programmes for a broad array of healthcare brands. "
target: System Analytic Ltd.
System Analytic Ltd. owns and operates a database and online tools to help pharmaceutical companies to identify and engages opinion leaders. The company was incorporated in 2006 and is based in London, United Kingdom.
price ($mm)
rev ($mm)
$3
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
announced 3/8/2012 via PR Newswire

Diversified Agency Services, will acquire Medical Collective Intelligence Co. Ltd.

synopsis: Diversified Agency Services announced an agreement with ITOCHU Corporation and a number of venture capital funds to acquire a majority stake in Medical Collective Intelligence Co. Ltd., a highly respected Japanese online medical communications agency.
buyer parent: Omnicom Group Inc.
buyer: Diversified Agency Services
Diversified Agency Services (DAS), a division of Omnicom Group Inc., manages Omnicom's holdings in a variety of marketing disciplines. DAS includes more than 190 companies, which operate through a combination of networks and regional organizations. "
target parent: Itochu Corporation
target: Medical Collective Intelligence Co. Ltd.
Medical Collective Intelligence Co. Ltd. ("MCI") is a highly respected and well-known Japanese online medical communications agency. Based in Tokyo, MCI operates a Marketing Research division and a Detailing Solutions division, both focused on the healthcare industry.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 2/28/2020 via Company Press Release

JMDC Inc., will acquire MeCompany

synopsis: JMDC Inc., a company that provides medical data statistics, life insurance data statistics, health data platform management, and other services, will be acquiring MeCompany, a database company for medical institutions, dispensing pharmacies, and nursing care establishments using the SCUEL database.
buyer: JMDC Inc. (TSE:4483:$91.75)
JMDC Inc. offers information services. The Company provides medical data statistics, life insurance data statistics, health data platform management, and other services. JMDC provides its services throughout Japan. "
target: MeCompany
Based in Japan, MeCompany is a database company for medical institutions, dispensing pharmacies, and nursing care establishments using the SCUEL database. MeCompany strives to develop a matching service that creates encounters between medical institutions and pharmacies and patients
price ($mm)
$9.76
rev ($mm)
$2
EBITDA ($mm)
EV / rev
4.4x
EV / EBITDA
closed 1/6/2017 via PR Newswire

InVitae, acquired AltaVoice

synopsis: Invitae Corporation has acquired AltaVoice, a privately owned, patient-centered data company with a global platform for collecting, curating, coordinating, and delivering safeguarded data from patients and clinicians.
buyer: InVitae (NVTA:$216.82)
Invitae, a genetic information company, is aggregating the worlds genetic tests into a single service with better quality, faster turnaround time and lower price than most single-gene tests today. Our mission is to bring genetic information into routine medical practice to improve the quality of hea"
target: AltaVoice
AltaVoice is a patient-centered data company with an innovative story and business model that optimizes the search for better treatments for diseases. They build and host Patient Insights Networks (PINs).
price ($mm)
$5.00
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/26/2015 via Company Press Release

Inovalon, Inc., will acquire Avalere Health LLC

synopsis: Inovalon, a leading technology company providing cloud-based analytics and data-driven intervention platforms to the healthcare industry, has entered into a definitive agreement to acquire Avalere Health, Inc., a leading provider of data-driven advisory services and business intelligence solutions to the pharmaceutical and life sciences industry.
buyer: Inovalon, Inc. (INOV:$449.36)
Inovalon is a leading technology company that combines advanced cloud-based data analytics and data-driven intervention platforms to achieve meaningful insight and impact in clinical and quality outcomes, utilization, and financial performance across the healthcare landscape. "
target: Avalere Health LLC
Avalere Health, Inc. is a leading provider of data-driven advisory services and business intelligence solutions to the pharmaceutical and life sciences industry.
price ($mm)
$140
rev ($mm)
$47
EBITDA ($mm)
EV / rev
3.0x
EV / EBITDA
announced 3/7/2018 via GlobeNewswire

Inovalon, Inc., will acquire Ability Network, Inc.

synopsis: Inovalon, a leading technology company, announced it has entered into a definitive agreement to acquire ABILITY Network, a leading information technology company helping providers and payers simplify the administrative and clinical complexities of healthcare.
buyer: Inovalon, Inc. (INOV:$449.36)
Inovalon is a leading technology company that combines advanced cloud-based data analytics and data-driven intervention platforms to achieve meaningful insight and impact in clinical and quality outcomes, utilization, and financial performance across the healthcare landscape. "
target parent: Summit Partners
target: Ability Network, Inc.
ABILITY® Network is a leading information technology company helping providers and payers simplify the administrative and clinical complexities of healthcare through innovative applications and data analytics. ABILITY is headquartered in Minneapolis with principal offices in Boston and Tampa.
price ($mm)
$1,200
rev ($mm)
$140
EBITDA ($mm)
$72
EV / rev
8.6x
EV / EBITDA
16.6x
closed 10/3/2016 via GlobeNewswire

Inovalon, Inc., acquired Creehan & Company

synopsis: Inovalon has completed its acquistion of Creehan Holding Co., Inc., the parent company of Creehan & Company, an independent provider of specialty pharmacy and specialty medications management software-as-a-service platforms. Creehan & Company’s software platform is utilized by approximately 30% of the specialty pharmacy market.
buyer: Inovalon, Inc. (INOV:$449.36)
Inovalon is a leading technology company that combines advanced cloud-based data analytics and data-driven intervention platforms to achieve meaningful insight and impact in clinical and quality outcomes, utilization, and financial performance across the healthcare landscape. "
target: Creehan & Company
Creehan & Company is the healthcare technology industry’s leading third-party provider of SaaS and on-premise enterprise-wide software application platforms and implementation services for standalone specialty pharmacies and other industry players.
price ($mm)
$105
rev ($mm)
$27
EBITDA ($mm)
EV / rev
4.8x
EV / EBITDA
announced 8/26/2015 via Company Press Release

Inovalon, Inc., will acquire Avalere Health LLC

synopsis: Inovalon, a leading technology company providing cloud-based analytics and data-driven intervention platforms to the healthcare industry, has entered into a definitive agreement to acquire Avalere Health, Inc., a leading provider of data-driven advisory services and business intelligence solutions to the pharmaceutical and life sciences industry.
buyer: Inovalon, Inc. (INOV:$449.36)
Inovalon is a leading technology company that combines advanced cloud-based data analytics and data-driven intervention platforms to achieve meaningful insight and impact in clinical and quality outcomes, utilization, and financial performance across the healthcare landscape. "
target: Avalere Health LLC
Avalere Health, Inc. is a leading provider of data-driven advisory services and business intelligence solutions to the pharmaceutical and life sciences industry.
price ($mm)
$140
rev ($mm)
$47
EBITDA ($mm)
EV / rev
3.0x
EV / EBITDA
closed 9/14/2009 via BusinessWire

MedAssurant, Inc., acquired Catalyst Information Technologies, Inc.

synopsis: MedAssurant, Inc., a leading provider of data-driven healthcare solutions, announced that it has acquired Catalyst Information Technologies, Inc., d/b/a Catalyst Technologies, a leader in healthcare clinical quality outcomes analysis and data analytical toolset development.
buyer: MedAssurant, Inc. (INOV:$449.36)
MedAssurant, Inc. is a leading healthcare solutions provider focused on the importance of healthcare data and its ability to drive dramatic, objective improvements in clinical and quality outcomes, care management, and financial performance throughout the healthcare community. "
target: Catalyst Information Technologies, Inc.
Catalyst Technologies is the provider of an advanced suite of data mining tools that enable large-scale healthcare data analytics through user-friendly interfaces, provoking significant change and action in its customers’ business by providing expert resource to transform data into information.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/22/2017 via PR Web

JVION, LLC, purchased Healthcare IT practice from Predixion Software

synopsis: Atlanta-based Jvion, the leading cognitive clinical science machine firm, announced the acquisition of the predictive analytic firm Predixion’s Healthcare IT practice. Atlanta-based Jvion, the leading cognitive clinical science machine firm, announced the acquisition of the predictive analytic firm Predixion’s Healthcare IT practice.
buyer: JVION, LLC
Jvion delivers a Cognitive Clinical Success Machine that serves as a high-performance appliance. It activates recommendations that help healthcare providers who need ultra-definition patient-level predictions, prioritizations, interventions, and suggestions. "
seller parent: GreenWave Systems
seller: Predixion Software
Predixion’s Healthcare IT practice provides predictive analysis to healthcare providers. Predixion has had great success. Most notably, they have helped Carolina’s Health System empower their nursing staff with insights and processes that have led to a reduction in the provider’s readmission rate.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 4/13/2015 via PR Newswire

IBM Watson Health, will acquire Explorys, Inc.

synopsis: IBM announced plans to acquire Explorys, a healthcare intelligence cloud company that has built one of the largest clinical data sets in the world, representing more than 50 million lives. Explorys provides secure cloud-based solutions for clinical integration, at-risk population management, cost of care measurement, and pay-for-performance.
buyer parent: IBM
buyer: IBM Watson Health
IBM Watson Health Cloud will bring together clinical, research and social data from a diverse range of health sources, creating a secure, cloud-based data sharing hub, powered by the most advanced cognitive and analytic technologies. "
target: Explorys, Inc.
Originally inspired by physicians and informatics leaders, Explorys combines the most powerful healthcare computing platform in the world with turnkey solutions for clinical integration, at-risk population management, cost of care measurement, and pay-for-performance solutions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/15/2020 via PR Newswire

Unified Women’s Healthcare, LLC, acquired Lucina Health

synopsis: Unified Women's Healthcare has acquired the assets of Lucina Health, a company dedicated to improving healthcare for women and babies.  Operating within the Unified family as Lucina Analytics, the company supports payors and providers with big data insights and advanced analytics.
buyer: Unified Women’s Healthcare, LLC
Unified Women's Healthcare, headquartered in Boca Raton, FL, was founded in 2009 as a single-specialty Management Services Organization. Today, the company assists Ob-Gyn practices to grow and thrive through operational and business support services in a unique, yet complementary model. "
target: Lucina Health
Lucina, located in Louisville, Kentucky, is a data-driven, enterprise SaaS company that delivers the leading women's maternity analytics platform to innovative health plans, Medicaid providers and public entities.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/3/2019 via BNC Analysis

Abeo, Inc., acquired Trusted i10

synopsis: abeo, a leader in physician-focused billing and practice management solutions, has acquired Trusted i10. Trusted i10 has proven next generation technology that solves the issue of medical record data overload. Through technology, they process copious amounts of free text data and turn it into actionable information.
buyer parent: Parthenon Capital Partners
buyer: Abeo, Inc.
abeo Management Corporation (abeo) serves as a leading source of revenue cycle management and practice management for hospital-based specialties, originating from deep-rooted experience within Anesthesiology. "
target: Trusted i10
Trusted i10 has proven next generation technology that solves the issue created by modern electronic medical systems: medical record data overload. Through technology, they process copious amounts of free text data and turn it into actionable information.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/28/2019 via BusinessWire

Clinigence, LLC. merged with iGambit, Inc.,

synopsis: Clinigence Holdings, Inc. has become a publicly-traded company via a reverse merger with iGambit, Inc. Clinigence is a healthcare information technology company providing an advanced, cloud-based platform for healthcare organizations.
buyer: iGambit, Inc. (OTCPK:IGMB:$0.06)
iGambit is a fully reporting publicly-held company focused on medical technology markets. iGambit's primary mission is the expansion of its newly acquired medical technology business HealthDatix Data Analytics Health. "
target: Clinigence, LLC. (OTCPK:IGMB.D:$1.37)
Clinigence Holdings is a leading healthcare information technology company providing an advanced, cloud-based platform that enables healthcare organizations to provide value-based care and population health management.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/22/2019 via BusinessWire

QualMetrix merged with Clinigence, LLC.,

synopsis: Clinigence, LLC and QualMetrix, Inc., two pioneering healthcare information technology companies providing advanced, cloud-based platforms that enable healthcare organizations to shift to value-based care reimbursements and to provide population health management, have completed their merger.
buyer: Clinigence, LLC. (OTCPK:IGMB.D:$1.37)
Clinigence Holdings is a leading healthcare information technology company providing an advanced, cloud-based platform that enables healthcare organizations to provide value-based care and population health management. "
target: QualMetrix
QualMetrix, founded in 2013 and based in Miramar, Florida, is a population health analytics company that provides turnkey solutions that enable connected intelligence across the care continuum by transforming massive amounts of clinical and claims data into actionable insights.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/21/2017 via PR Newswire

Parallax Health Sciences, Inc., acquired ProEventa, Inc.

synopsis: Parallax Health Sciences, Inc. and its wholly-owned subsidiary Parallax Behavioral Health, Inc. announced that it has acquired all of the assets of ProEventa, Inc. Proeventa is the owner of an industry first and proven Goal Mastery Platform known as REBOOT, a platform designed to improve Health Treatment Outcomes using Behavioral technology.
buyer: Parallax Health Sciences, Inc. (OTCPK:PRLX:$18.98)
Parallax Health Sciences, Inc. is an innovative biomedical healthcare company delivering consumer-centric products and services in the areas of pharmaceuticals, digital health and remote patient monitoring, behavioral health and point of care diagnostics. "
target parent: Grafton Integrated Health Network
target: ProEventa, Inc.
ProEventa, Inc. is the owner of an industry first and proven Goal Mastery Platform known as REBOOT. Reliable Evidenced Based Outcomes Optimization Technologies is a technology platform specifically designed to Improve Health Treatment Outcomes using Proprietary Behavioral technology systems.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/7/2017 via PR Newswire

Omega Healthcare, acquired WhiteSpace Health Inc

synopsis: Omega Healthcare Management Services announced that it has finalized the acquisition of WhiteSpace Health - a US-based healthcare analytics company with a development facility in Hyderabad, India. This move enhances the services provided by Omega Healthcare as well as giving it a new geographical footprint, its 5th in India.
buyer: Omega Healthcare
Omega Healthcare Management Services, a front-runner in the healthcare service space in India was founded in 2004. Omega handles high-end, value-driven work pertaining to medical coding, Revenue Cycle Management (RCM) and related work for large US based companies. "
target: WhiteSpace Health Inc
WhiteSpace Health is a US-based healthcare analytics company. WhiteSpace Health's guided business intelligence platform enables better patient outcomes and improved financial performance. The solutions help healthcare providers improve practice engagement, reduce cost, and improve productivity.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/19/2016 via BusinessWire

Trendshift, LLC, acquired Health Data Intelligence, LLC

synopsis: TrendShift, LLC, a SaaS-based Decision Analytics and Risk Assessment company, acquired Health Data Intelligence, LLC (“HDI”), a SaaS-based healthcare analytics and population health management company based in Columbus, Ohio, serving employers, benefit advisors, medical managers and payers.
buyer: Trendshift, LLC
Founded in 2012, TrendShift is a SaaS-based Decision Analytics and Risk Assessment company serving a wide range of constituents. They have created an unrivaled suite of powerful SaaS-based applications for healthcare risk holders that promises to disrupt the industry status quo. "
target: Health Data Intelligence, LLC
Health Data Intelligence’s flagship product is the CarePlan Enterprise Analytics Suite, a powerful easy-to-use analytics platform that enables healthcare professionals to make better-informed decisions in order to improve the quality of patient care and financial outcomes for their organization.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 7/20/2016 via BusinessWire

Philips Electronics NV, will acquire WellCentive, LLC

synopsis: Royal Philips announced that it has signed an agreement to acquire Wellcentive, a leading US-based provider of population health management software solutions. Wellcentive's applications will be integrated in the Philips HealthSuite cloud, the company’s digital enabler for the next generation of connected health solutions.
buyer: Philips Electronics NV (ENXTAM:PHIA:$20,876.84)
Royal Philips Electronics is a global leader in healthcare, lighting and consumer lifestyle, delivering products, services and solutions. The company has medical diagnostic imaging and patient monitoring systems, energy efficient lighting solutions, home appliances, as well as consumer electronics. "
target: WellCentive, LLC
Wellcentive is a leading US-based provider of population health management software solutions. Wellcentive’s analytics simplify complex data from all points of care, advancing comprehensive care management and payer collaboration.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/6/2016 via PR Newswire

Centauri Health Solutions, acquired IMI Health, Inc.

synopsis: Centauri Health Solutions, Inc.(SM), a provider of risk adjustment and quality healthcare solutions, has acquired Nashville-based IMI Health, whose cloud-based products provide real-time data-sharing that assist in closing gaps in care, improving care management and quality scores, and ensuring compliance with government regulations.
buyer: Centauri Health Solutions
Centauri Health Solutions focuses on revealing care opportunities through its suite of products and services. Delivering data-driven services through cloud-based software solutions, the firm provides data management designed specifically for risk adjustment and quality-based revenue programs. "
target: IMI Health, Inc.
IMI Health has transformed healthcare data for millions of members into reliable, actionable information. Their core business is focused on supporting quality teams at health care organizations to quickly and accurately produce HEDIS reports and to identify gaps in care throughout the year.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/23/2013 via BNC Analysis

Optum, acquired Humedica

synopsis: Optum has acquired Humedica. Humedica is the clinical intelligence company that powers health care providers, life sciences and research organizations to make better-informed, more confident decisions by transforming unconnected data from multiple sources into real-world insights.
buyer parent: UnitedHealth Group
buyer: Optum
Optum, through its subsidiaries, provides information and technology-enabled health services. It offers health management solutions that address the physical, mental, and financial needs of individuals and organizations. "
target: Humedica
Humedica is the clinical intelligence company that powers health care providers and life sciences organizations to make better-informed, more confident decisions by transforming unconnected data from multiple sources into real-world insights.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 11/6/2012 via Company Press Release

McKesson Corporation, will acquire Emendo Ltd

synopsis: McKesson announced it has entered a definitive agreement to acquire Emendo Ltd., whose CapPlan Predictive Capacity Planning solution equips healthcare providers to optimize operational performance by intelligently forecasting patient demand.
buyer: McKesson Corporation (MCK:$214,319.00)
McKesson Corporation is a healthcare services and information technology company dedicated to making the business of healthcare run better. McKesson partners with payers, hospitals, physician offices, pharmacies, pharmaceutical companies and others across the spectrum of care. "
target: Emendo Ltd
Emendo’s CapPlan solution enables over 40 hospitals throughout New Zealand, Australia, Canada and the UK to forecast patient demand and plan resourcing.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/18/2012 via Market Wire

Sharecare, Inc., acquired PKC Corp.

synopsis: Sharecare®, the health and wellness social network co-founded by Jeff Arnold and two-time Emmy® Award-winning television host, Dr. Mehmet Oz, announced its acquisition of PKC Corporation, a leading developer of healthcare decision support software that empowers patients and providers with individualized medical knowledge.
buyer: Sharecare, Inc.
Launched in 2010 and based in Atlanta, GA, Sharecare is an interactive, social Q & A platform that allows people to ask, learn and act upon questions of health and wellness. The company's innovative approach provides the consumer access to a wide array of health and wellness experts. "
target: PKC Corp.
PKC Corporation designs and builds healthcare decision support software that captures patient data and generates differential diagnoses and management plans. Its software offerings include Profiler, Advisor and Explorer.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 7/15/2019 via Company Press Release

SPH Analytics, will acquire SA Ignite, Inc.

synopsis: SPH Analytics, a top-ranked Population Health Management vendor, announced that the SPH Analytics’ population health line of business will merge with SA Ignite. SA Ignite helps healthcare providers achieve top performance scores and financial incentives in MIPS with their IgniteMIPS software and deep domain, technical and data expertise.
buyer parent: Symphony Technology Group
buyer: SPH Analytics
SPH Analytics, a leader in healthcare analytics and population health management, empowers clients to analyze and interpret their clinical, financial, and consumer experience data to maximize their performance. SPH’s solutions include Population Care, Population Value, and Population Engage. "
target: SA Ignite, Inc.
SA Ignite helps healthcare providers achieve top performance scores and financial incentives in MIPS with their IgniteMIPS software and deep domain, technical and data expertise.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/14/2020 via PR Web

Amsys Group, acquired HealthConnexx LLC

synopsis: AMSYS Group, an international group of companies, has acquired HealthConnexx, a healthcare technology company. HealthConnexx, through its RxConnexx platform, connects providers, patients, payers, pharmacies, and pharmaceutical companies to prescription medication information to enable better clinical outcomes through real-time data.
buyer: Amsys Group
AMSYS Group is a 17-year old firm with experience in multiple verticals. IT is their flagship vertical. The group offers a variety of managed IT services and IT staffing solutions. Their other verticals include emerging tech, telecom engineering, oil and gas services, compliance, and healthcare. "
target: HealthConnexx LLC
HealthConnexx is an innovator for healthcare data liquidity and accessibility. The HealthConnexx RxConnexx platform is the first real-time patient data exchange platform for medication and benefits data, bringing immediate clarity and actionable information for everyone in the healthcare continuum.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/20/2012 via BusinessWire

Pharmaceutical Strategies Group, LLC, acquired Artemetrx

synopsis: Pharmaceutical Strategies Group, LLC, America’s largest independent pharmacy benefits consulting firm, has closed on its acquisition of Artemetrx Health Resources. Artemetrx offers data analytic tools and clinical programs that integrate pharmacy, medical, and other healthcare information.
buyer: Pharmaceutical Strategies Group, LLC
Pharmaceutical Strategies Group, LLC assists plan sponsors and other payors, Taft-Hartley Unions, large employers, and health systems in designing, implementing, and managing programs that maximize the value and impact of pharmaceuticals in their population. "
target: Artemetrx
At the core of the Artemetrx service offering is a robust proprietary data aggregation engine that combines behavioral, medical, dental, vision, lab, and prescription drug data to provide a comprehensive view of health-related utilization and expenditures.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/17/2019 via PE Hub

EMV Capital Ltd, acquired Wanda Health

synopsis: EMV Capital, a London-based early-stage venture investor, has acquired Wanda Inc from NetScientific, a transatlantic healthcare IP commercialisation group. Wanda is a digital health company that offers advanced clinical decision support software powered by machine learning to improve and simplify life for people with serious health risks.
buyer: EMV Capital Ltd
EMV Capital (EMVC) is a London-based early-stage venture investor focused on B2B companies in the industrial high-tech, energy, circular economy, smart cities, transportation and healthcare sectors. EMVC’s investments cover a range of technologies, including AI, machine learning, IoT, and more. "
target parent: NetScientific
target: Wanda Health
Wanda is a digital health company. Wanda offers advanced clinical decision support software powered by machine learning and real time patient data analysis to improve and simplify life for people with serious health risks. Wanda empowers clinically guided interventions to prevent rehospitalizations.
price ($mm)
$0.20
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 2/15/2018 via Company Press Release

Roche Ltd, will acquire Flatiron Health

synopsis: Flatiron Health, Inc. announced that it has signed a definitive agreement under which Roche will acquire all shares of Flatiron Health. Flatiron Health is a healthcare technology and services company focused on accelerating cancer research and improving patient care.
buyer: Roche Ltd
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare. "
target: Flatiron Health
Flatiron Health is a healthcare technology and services company focused on accelerating cancer research and improving patient care. The Flatiron platform enables cancer researchers and care providers to learn from the experience of every patient.
price ($mm)
$1,900*
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/10/2020 via PR Web

HealthLytix merged with Cortechs Labs Inc,

synopsis: CorTechs Labs Inc., the leading quantitative neuroimaging software company, announced that it has merged with sister company HealthLytix, a healthcare technology company developing new applications in genetics and medical imaging to improve the screening and early detection of cancer and neurodegenerative diseases.
buyer: Cortechs Labs Inc
CorTechs Labs is the leader in radiology AI applications, using cutting-edge advances in medical imaging to revolutionize disease screening and early detection so people can enjoy longer, better lives. "
target: HealthLytix
HealthLytix is a precision health company and developer of quantitative medical imaging solutions that leverage machine learning. HealthLytix creates data analytics solutions to provide comprehensive insights into health status based on genetics, quantitative imaging, and other medical information.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like Avalere Health LLC


read more

Avalere Health LLC

Dymaxium, Inc.

Vidal Group

MedicalDirector

Decision Resources Group

Edital

Prous Science

Infinata, Inc.

Decision Resources, Inc.

Decision Resources, Inc.

Pharmaspectra

SpringerProtocols

NHiS Ltd

TargetRx, Inc.

AlphaImpactRx, Inc

ImpactRx, Inc.

System Analytic Ltd.

Medical Collective Intelligence Co. Ltd.

MeCompany

AltaVoice

read more

Avalere Health LLC

read more

Ability Network, Inc.

Creehan & Company

Avalere Health LLC

Catalyst Information Technologies, Inc.

read more

Predixion Software

Explorys, Inc.

Lucina Health

Trusted i10

Clinigence, LLC.

QualMetrix

ProEventa, Inc.

WhiteSpace Health Inc

Health Data Intelligence, LLC

WellCentive, LLC

IMI Health, Inc.

Humedica

Emendo Ltd

PKC Corp.

SA Ignite, Inc.

HealthConnexx LLC

Artemetrx

Wanda Health

Flatiron Health

HealthLytix

Geography
Matching Companies
Ticker: TSE:2413
 
 
 
 
 
 
 
 
M3.com
M3.com
M3.com is Japan's largest portal site dedicated to healthcare professionals. M3.com provides the latest medical news, overseas journal article summaries, and medical resources. The portal offers information on clinical trials and other services in the healthcare and pharmaceutical industries.
year
2019
rev ($mm)
$1,015.17
EBITDA ($mm)
$288.13
EBIT ($mm)
$275.64
Net Income ($mm)
$175.78
Employees
5165
  • drill down
  • watch
Ticker: TSE:2413
 
 
 
 
 
 
 
 
M3, Inc.
M3 Inc. represents the three Ms of Medicine, Media, and Metamorphosis. Their company was founded with the goal of changing the world of medicine through making full use of the power of the Internet.
year
2019
rev ($mm)
$1,127.03
EBITDA ($mm)
$319.84
EBIT ($mm)
$286.78
Net Income ($mm)
$193.56
Employees
6024
  • drill down
  • watch
Ticker: INOV
 
 
 
 
 
 
 
 
Inovalon, Inc.
Inovalon, Inc.
Inovalon is a leading technology company that combines advanced cloud-based data analytics and data-driven intervention platforms to achieve meaningful insight and impact in clinical and quality outcomes, utilization, and financial performance across the healthcare landscape.
year
2017
rev ($mm)
$449.36
EBITDA ($mm)
$75.91
EBIT ($mm)
$27.16
Net Income ($mm)
$34.82
Employees
2119
  • drill down
  • watch
Ticker: OTCPK:IGMB.D
 
 
 
 
 
 
 
 
Clinigence, LLC.
Clinigence Holdings, a fully reporting, publicly-held company, is a leading healthcare information technology company providing an advanced, cloud-based platform that enables healthcare organizations to provide value-based care and population health management.
year
2018
rev ($mm)
$1.37
EBITDA ($mm)
($0.84)
EBIT ($mm)
($0.84)
Net Income ($mm)
Employees
0
  • drill down
  • watch
Ticker: OTCQB: EHVVF
 
 
 
 
 
 
 
 
Ehave, Inc.
Ehave, Inc.
Ehave is a healthcare company developing a next generation of digital solutions for stakeholders in the medical cannabis and mental health sectors. Ehave’s health informatics platform efficiently captures high-quality, objective user data.
year
2018
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
($0.76)
Net Income ($mm)
Employees
0
  • drill down
  • watch
Ticker: ASX:PKS
 
 
 
 
 
 
 
 
Pacific Knowledge Systems
Pacific Knowledge Systems
Pacific Knowledge Systems (PKS) is an Australian provider of clinical expert intelligence. Their RippleDown solution integrates patient data with a knowledge base that is managed by clinical domain experts, to deliver patient-specific reports, recommendation and alerts.
year
2019
rev ($mm)
$1.38
EBITDA ($mm)
($0.20)
EBIT ($mm)
($0.18)
Net Income ($mm)
Employees
0
  • drill down
  • watch
Ticker: ASX:VHT
 
 
 
 
 
 
 
 
Volpara Solutions
Volpara Solutions
Volpara Health Technologies Limited (VHT) is a New Zealand MedTech Software as a Service company. VHT is a leading provider of breast imaging analytics products that improve clinical decision-making and the early detection of breast cancer. Volpara Solutions is the sales and marketing arm of VHT.
year
2019
rev ($mm)
$3.29
EBITDA ($mm)
($7.96)
EBIT ($mm)
($8.08)
Net Income ($mm)
Employees
53
  • drill down
  • watch
Ticker: CM:CLRX
 
 
 
 
 
 
 
 
CollabRX, Inc
CollabRX, Inc
CollabRx, Inc. is a recognized leader in cloud-based expert systems to inform healthcare decision-making. CollabRx uses information technology to aggregate and contextualize the world's knowledge on genomics-based medicine with specific insights from the nation's top cancer experts.
year
2014
rev ($mm)
$0.38
EBITDA ($mm)
($4.07)
EBIT ($mm)
($4.32)
Net Income ($mm)
Employees
1
  • drill down
  • watch
Ticker: OM:RTC
 
 
 
 
 
 
 
 
Rethinking Care AB
Rethinking Care AB
Rethinking Care introduces a holistic concept in nursing & health, based on 3 interacting spheres of activity - "Software as a service", "Care as a service" & "Health as a service", based on a high level of competence in nursing & healthcare services as well as IT tools developed for health care.
year
2016
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: DB:COP
 
 
 
 
 
 
 
 
CompuGroup Medical AG
CompuGroup Medical AG
CompuGroup Medical is a leading global eHealth provider. Their software and communications solutions assist doctors, dentists, hospitals, pharmacists, associations, networks and other service providers with workflow, diagnosis and therapy.
year
2019
rev ($mm)
$879.35
EBITDA ($mm)
$200.48
EBIT ($mm)
$134.28
Net Income ($mm)
$82.69
Employees
5171
  • drill down
  • watch
Ticker: AIM:EMIS
 
 
 
 
 
 
 
 
EMIS Group PLC
EMIS Group PLC
Egton Medical Information Systems Ltd (EMIS) is the UK's market leading primary care software provider with more than 39 million patient records entrusted to its systems. Its aim is to make good quality, timely patient information available any time, any where through interoperable systems.
year
2018
rev ($mm)
$216.76
EBITDA ($mm)
$33.15
EBIT ($mm)
$21.39
Net Income ($mm)
$14.24
Employees
2046
  • drill down
  • watch
Ticker: EVH
 
 
 
 
 
 
 
 
Evolent Health
Evolent Health
Evolent partners with leading health systems to drive value-based care transformation. By providing clinical, analytical and financial capabilities, Evolent helps physicians and health systems achieve superior quality and cost results.
year
2016
rev ($mm)
$212.24
EBITDA ($mm)
($39.30)
EBIT ($mm)
($52.25)
Net Income ($mm)
Employees
946
  • drill down
  • watch
Ticker: TRHC
 
 
 
 
 
 
 
 
Tabula Rasa Healthcare
Tabula Rasa Healthcare
Tabula Rasa HealthCare (TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk.
year
2018
rev ($mm)
$204.27
EBITDA ($mm)
$16.27
EBIT ($mm)
$1.63
Net Income ($mm)
Employees
952
  • drill down
  • watch
Ticker: MTBC
 
 
 
 
 
 
 
 
Medical Transcription Billing, Corp.
Medical Transcription Billing, Corp.
MTBC (Medical Transcription Billing, Corp) is a healthcare information technology company that provides a fully integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers, revenue cycle management companies and software vendors.
year
2019
rev ($mm)
$65.19
EBITDA ($mm)
$1.78
EBIT ($mm)
($1.62)
Net Income ($mm)
Employees
2400
  • drill down
  • watch
Ticker: TSXV:BIO
 
 
 
 
 
 
 
 
AioCare
AioCare
AioCare, formerly known as Biosign Technologies, develops and sells cloud-based healthcare software products that address the needs in clinic management, home care operations, health monitoring and virtual care management. Their cutting edge technology is transforming Healthcare delivery in Germany.
year
2015
rev ($mm)
$0.38
EBITDA ($mm)
($3.04)
EBIT ($mm)
($3.43)
Net Income ($mm)
$1.21
Employees
16
  • drill down
  • watch
Ticker: TSXV:MSD
 
 
 
 
 
 
 
 
Moseda Technologies, Inc.
Moseda Technologies, Inc.
Moseda Technologies is a software developer of secure mobile health and telemedicine solutions for the healthcare sector. Their SmartCare solution integrates the latest in mobile, wearables and SaaS technology to provide increased levels of efficiency and reduction in redundant administrative tasks.
year
2015
rev ($mm)
$0.02
EBITDA ($mm)
($1.86)
EBIT ($mm)
($1.86)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: ZMD
 
 
 
 
 
 
 
 
ZoomMed Inc.
ZoomMed Inc.
Zoommed Inc. develops and markets various computer applications for healthcare professionals in Canada. The company builds and operates the ZoomMed Communication Network, a clinical interoperable information exchange network between physicians and various other stakeholders of the healthcare sector.
year
2014
rev ($mm)
$6.08
EBITDA ($mm)
$2.65
EBIT ($mm)
$2.78
Net Income ($mm)
Employees
40
  • drill down
  • watch